Antitumor Activity of s-Triazine Derivatives: A Systematic Review
Molecules · 23.05.2023 · 28 (11) · 4278
DOI: 10.3390/molecules28114278 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Molecules, online erschienen am 23.05.2023. Verfasst von Qiuzi Dai und 8 weiteren Autor:innen. Beteiligte Einrichtung: The Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, Hunan Key Laboratory of the Resea…. Hauptthemen laut MEDLINE: Antineoplastic Agents, Breast Neoplasms. Die Arbeit wurde bisher 106-mal zitiert (Crossref) und nennt 66 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Hunan Province, Shenzhen Bay Laboratory Open Funding.
Abstract (Originalsprache)
1,3,5-triazine derivatives, also called s-triazines, are a series of containing-nitrogen heterocyclic compounds that play an important role in anticancer drug design and development. To date, three s-triazine derivatives, including altretamine, gedatolisib, and enasidenib, have already been approved for refractory ovarian cancer, metastatic breast cancer, and leukemia therapy, respectively, demonstrating that the s-triazine core is a useful scaffold for the discovery of novel anticancer drugs. In this review, we mainly focus on s-triazines targeting topoisomerases, tyrosine kinases, phosphoinositide 3-kinases, NADP+-dependent isocitrate dehydrogenases, and cyclin-dependent kinases in diverse signaling pathways, which have been extensively studied. The medicinal chemistry of s-triazine derivatives as anticancer agents was summarized, including discovery, structure optimization, and biological applications. This review will provide a reference to inspire new and original discoveries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Hunan Provincial University Key Laboratory of the Fundamental and Clinical Research on Functional Nucleic Acid, Hunan Key Laboratory of the Research and Development of Novel Pharmaceutical Preparations, Changsha Med…
- State Key Laboratory of Chemical Oncogenomics, Tsinghua Shenzhen International Graduate School, Shenzhen 518055, China.
- Institute of Biomedical Health Technology and Engineering, Shenzhen Bay Laboratory, Shenzhen 518132, China.
- School of Pharmaceutical Sciences, Tsinghua University, Beijing 100084, China.
Förderung
- the Natural Science Foundation of Hunan Province
- Shenzhen Bay Laboratory Open Funding
Zitieren
APA
Dai, Q., Sun, Q., Ouyang, X., Liu, J., Jin, L., Liu, A., He, B., Fan, T., & Jiang, Y. (2023). Antitumor Activity of s-Triazine Derivatives: A Systematic Review. Molecules, 28(11), 4278. https://doi.org/10.3390/molecules28114278
Vancouver
Dai Q, Sun Q, Ouyang X, Liu J, Jin L, Liu A, et al. Antitumor Activity of s-Triazine Derivatives: A Systematic Review. Molecules. 2023;28(11):4278. doi:10.3390/molecules28114278
BibTeX
@article{Dai2023,
author = {Dai, Qiuzi and Sun, Qinsheng and Ouyang, Xiaorong and Liu, Jinyang and Jin, Liye and Liu, Ahao and He, Binsheng and Fan, Tingting and Jiang, Yuyang},
title = {Antitumor Activity of s-Triazine Derivatives: A Systematic Review},
journal = {Molecules},
year = {2023},
volume = {28},
number = {11},
pages = {4278},
doi = {10.3390/molecules28114278}
}
EUVIMED